Agile Therapeutics to Participate in Upcoming March Investor Events

Rhea-AI Summary

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, announced that CEO Al Altomari will participate in two investor conferences. The first is the Oppenheimer 32nd Annual Virtual Healthcare Conference on Thursday, March 17, 2022, at 2:00 p.m. ET, featuring a fireside chat. The second is the Maxim Group and M-Vest 2022 Virtual Growth Conference, with a live panel discussion titled Advances in Women’s Health, from Clinical to Commercial, scheduled for Monday, March 28, 2022, at 3:00 p.m. ET. More information is available on their website.

PRINCETON, N.J., March 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will participate in two upcoming investor conferences, including a live panel discussion on drug development in Women’s Health.

• Oppenheimer’s 32^nd Annual Virtual Healthcare Conference
  • Fireside Chat
    • Thursday, March 17, 2022 at 2:00 p.m. ET
      
      
• Maxim Group and M-Vest 2022 Virtual Growth Conference
  
  • Advances in Women’s Health, from Clinical to Commercial Live Panel Discussion
    • Monday, March 28, 2022 at 3:00 p.m. ET
      

Links and webcast information for each conference can be found on the Investors section of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. Each archived webcast will be available for 30 days.

About Agile Therapeutics, Inc.
Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla^®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion^®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

FAQ

What is Agile Therapeutics planning for March 2022?

Agile Therapeutics will host CEO Al Altomari at two investor conferences in March 2022.

When is Agile Therapeutics participating in the Oppenheimer Conference?

The Oppenheimer Conference is scheduled for March 17, 2022, at 2:00 p.m. ET.

What topic will be discussed at the Maxim Group Conference?

The topic will cover 'Advances in Women’s Health, from Clinical to Commercial'.

When is the Maxim Group Conference taking place?

The Maxim Group Conference will occur on March 28, 2022, at 3:00 p.m. ET.

Where can I find more information about the upcoming Agile Therapeutics conferences?

More details can be found on the Agile Therapeutics Investors section of their website.